Tenaya Therapeutics (TNYA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.38, -6.69% vs the prior close of $0.41.
- Volume 6.79M shares, 2.4x its 50-day average (heavy).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
TNYA slides 6.7% to $0.38, a 52-week low on 2.4x normal volume. Closed at $0.38, -6.69% vs the prior close of $0.41. Day range $0.37–$0.42, opened at $0.41.
TNYA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — TNYA slides 6.7% to $0.38, a 52-week low on 2.4x normal volume
- Closed at $0.38, -6.69% vs the prior close of $0.41. Day range $0.37–$0.42, opened at $0.41.
- Volume was 6.79M shares, 2.4x its 50-day average of 2.82M — unusually heavy trading.
- Price is -40.6% vs its 50-day average ($0.64) and -47.7% vs its 200-day average ($0.73).
- 52-week range $0.36–$2.02; today's close sits at 1% of that range, 81.2% below the 52-week high.
Oct 15, 2026 — TNYA jumps 4.3% to $0.41
- Closed at $0.41, +4.35% vs the prior close of $0.39. Day range $0.39–$0.43, opened at $0.39.
- Volume was 5.00M shares, 1.8x its 50-day average of 2.79M.
- Price is -37.0% vs its 50-day average ($0.65) and -44.1% vs its 200-day average ($0.73).
- 52-week range $0.36–$2.04; today's close sits at 3% of that range, 80.0% below the 52-week high.
Oct 14, 2026 — TNYA slides 25.0% to $0.39, a 52-week low on 7.4x normal volume
- Closed at $0.39, -24.95% vs the prior close of $0.52. Day range $0.36–$0.51, opened at $0.50.
- Volume was 18.15M shares, 7.4x its 50-day average of 2.46M — unusually heavy trading.
- Price is -40.3% vs its 50-day average ($0.66) and -46.5% vs its 200-day average ($0.73).
- 52-week range $0.36–$2.07; today's close sits at 2% of that range, 81.1% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — TNYA slides 8.0% to $0.52, a 52-week low
- Closed at $0.52, -7.95% vs the prior close of $0.57. Day range $0.52–$0.57, opened at $0.57.
- Volume was 2.56M shares, 1.0x its 50-day average of 2.45M.
- Price is -21.3% vs its 50-day average ($0.66) and -29.0% vs its 200-day average ($0.73).
- 52-week range $0.52–$2.20; today's close sits at 0% of that range, 76.3% below the 52-week high.
Oct 12, 2026 — TNYA dips 2.4% to $0.57
- Closed at $0.57, -2.41% vs the prior close of $0.58. Day range $0.55–$0.58, opened at $0.56.
- Volume was 2.51M shares, 1.0x its 50-day average of 2.43M.
- Price is -15.0% vs its 50-day average ($0.67) and -22.9% vs its 200-day average ($0.73).
- 52-week range $0.52–$2.35; today's close sits at 2% of that range, 75.9% below the 52-week high.
Oct 9, 2026 — TNYA jumps 6.6% to $0.58 on 1.8x normal volume
- Closed at $0.58, +6.62% vs the prior close of $0.54. Day range $0.54–$0.59, opened at $0.54.
- Volume was 4.30M shares, 1.8x its 50-day average of 2.39M — unusually heavy trading.
- Price is -13.4% vs its 50-day average ($0.67) and -21.1% vs its 200-day average ($0.74).
- 52-week range $0.52–$2.35; today's close sits at 3% of that range, 75.3% below the 52-week high.
Oct 8, 2026 — TNYA rises 2.1% to $0.54
- Closed at $0.54, +2.06% vs the prior close of $0.53. Day range $0.52–$0.55, opened at $0.53.
- Volume was 3.64M shares, 1.6x its 50-day average of 2.34M.
- Price is -19.2% vs its 50-day average ($0.67) and -26.1% vs its 200-day average ($0.74).
- 52-week range $0.52–$2.35; today's close sits at 1% of that range, 76.9% below the 52-week high.
Oct 7, 2026 — TNYA dips 2.6% to $0.53, a 52-week low, 5 down days in a row
- Closed at $0.53, -2.56% vs the prior close of $0.55. Day range $0.53–$0.56, opened at $0.53.
- Volume was 3.72M shares, 1.6x its 50-day average of 2.30M.
- Price is -21.3% vs its 50-day average ($0.68) and -27.7% vs its 200-day average ($0.74).
- 52-week range $0.53–$2.35; today's close sits at 0% of that range, 77.3% below the 52-week high.
- That makes 5 straight losses.
Oct 6, 2026 — TNYA slides 3.0% to $0.55, a 52-week low, 4 down days in a row
- Closed at $0.55, -3.01% vs the prior close of $0.56. Day range $0.54–$0.58, opened at $0.57.
- Volume was 2.70M shares, 1.2x its 50-day average of 2.27M.
- Price is -19.7% vs its 50-day average ($0.68) and -25.8% vs its 200-day average ($0.74).
- 52-week range $0.53–$2.35; today's close sits at 1% of that range, 76.7% below the 52-week high.
- That makes 4 straight losses.
Oct 5, 2026 — TNYA ends flat (+0.0%) to $0.56, 3 down days in a row
- Closed at $0.56, +0.00% vs the prior close of $0.56. Day range $0.55–$0.58, opened at $0.56.
- Volume was 2.86M shares, 1.3x its 50-day average of 2.25M.
- Price is -17.8% vs its 50-day average ($0.69) and -23.6% vs its 200-day average ($0.74).
- 52-week range $0.53–$2.35; today's close sits at 2% of that range, 76.0% below the 52-week high.
- That makes 3 straight losses.
Oct 2, 2026 — TNYA dips 0.4% to $0.56, a 6-month low
- Closed at $0.56, -0.35% vs the prior close of $0.57. Day range $0.56–$0.58, opened at $0.57.
- Volume was 3.73M shares, 1.7x its 50-day average of 2.20M.
- Price is -18.3% vs its 50-day average ($0.69) and -23.7% vs its 200-day average ($0.74).
- 52-week range $0.53–$2.35; today's close sits at 2% of that range, 76.0% below the 52-week high.
TNYA latest news & SEC filings
Every SEC filing by or about TNYA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Sep 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 24, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Ali Faraz sold 5,020 shares at $0.71 (≈$3.56K) on Aug 17, 2026
- Ali Faraz sold 7,406 shares at $0.71 (≈$5.26K) on Aug 17, 2026
- Ali Faraz sold 5,837 shares at $0.71 (≈$4.14K) on Aug 17, 2026
- Ali Faraz sold 3,969 shares at $0.71 (≈$2.82K) on Aug 17, 2026
- Ali Faraz sold 5,020 shares at $0.71 (≈$3.56K) on Aug 17, 2026
- Ali Faraz sold 7,406 shares at $0.71 (≈$5.26K) on Aug 17, 2026
- …plus 10 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Tingley Whittemore sold 1,637 shares at $0.71 (≈$1.16K) on Aug 17, 2026
- Tingley Whittemore sold 1,871 shares at $0.71 (≈$1.33K) on Aug 17, 2026
- Tingley Whittemore sold 2,279 shares at $0.71 (≈$1.62K) on Aug 17, 2026
- Tingley Whittemore sold 1,637 shares at $0.71 (≈$1.16K) on Aug 17, 2026
- Tingley Whittemore sold 1,637 shares at $0.71 (≈$1.16K) on Aug 17, 2026
- Tingley Whittemore sold 1,871 shares at $0.71 (≈$1.33K) on Aug 17, 2026
- …plus 3 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 17, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 17, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 5, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 5, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.11M (prior year $0)
- Net income: -$43.39M (prior year -$23.28M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.20 (prior year -$0.14) (loss widened vs Jun 30, 2025)
Aug 5, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.02 — Ended a material agreement.
Jun 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade TNYA
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Mar 11, 2026, Nov 10, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.29% (largest 25.0%). That is a volatile stock.
- Liquidity: about 4.29M shares (≈$1.63M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.38 vs a range of $0.36–$2.02 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Faraz Ali sold 5,020 shares on Aug 17, 2026.
- Latest filings: 10-Q Aug 5, 2026; 8-K Aug 5, 2026; 8-K Jul 2, 2026.
- Share count: 224.23M shares outstanding (Jul 30, 2026), +37.6% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
TNYA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.41 | 0.42 | 0.37 | 0.38 | 6.79M |
| Oct 15, 2026 | 0.39 | 0.43 | 0.39 | 0.41 | 5.00M |
| Oct 14, 2026 | 0.50 | 0.51 | 0.36 | 0.39 | 18.15M |
| Oct 13, 2026 | 0.57 | 0.57 | 0.52 | 0.52 | 2.56M |
| Oct 12, 2026 | 0.56 | 0.58 | 0.55 | 0.57 | 2.51M |
| Oct 9, 2026 | 0.54 | 0.59 | 0.54 | 0.58 | 4.30M |
| Oct 8, 2026 | 0.53 | 0.55 | 0.52 | 0.54 | 3.64M |
| Oct 7, 2026 | 0.53 | 0.56 | 0.53 | 0.53 | 3.72M |
| Oct 6, 2026 | 0.57 | 0.58 | 0.54 | 0.55 | 2.70M |
| Oct 5, 2026 | 0.56 | 0.58 | 0.55 | 0.56 | 2.86M |
| Oct 2, 2026 | 0.57 | 0.58 | 0.56 | 0.56 | 3.73M |
| Oct 1, 2026 | 0.60 | 0.60 | 0.56 | 0.57 | 4.76M |
| Sep 30, 2026 | 0.61 | 0.62 | 0.60 | 0.60 | 1.81M |
| Sep 29, 2026 | 0.59 | 0.62 | 0.59 | 0.59 | 1.74M |
| Sep 28, 2026 | 0.60 | 0.61 | 0.57 | 0.59 | 6.08M |
| Sep 25, 2026 | 0.63 | 0.64 | 0.60 | 0.61 | 3.72M |
| Sep 24, 2026 | 0.66 | 0.67 | 0.62 | 0.62 | 3.59M |
| Sep 23, 2026 | 0.69 | 0.69 | 0.66 | 0.66 | 2.91M |
| Sep 22, 2026 | 0.67 | 0.70 | 0.67 | 0.68 | 1.23M |
| Sep 21, 2026 | 0.68 | 0.71 | 0.67 | 0.67 | 3.94M |
About Tenaya Therapeutics
Tenaya Therapeutics (TNYA) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in SOUTH SAN FRANCISCO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1858848.
TNYA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Faraz Ali | Chief Executive Officer | Sep 11, 2026 |
| Amy L. Burroughs | Director | May 29, 2026 |
| June Lee | Director | May 29, 2026 |
| Karah Herdman Parschauer | Director | May 29, 2026 |
| Deepak Srivastava | Director | May 29, 2026 |
| Catherine Stehman-Breen | Director | May 29, 2026 |
| Jeffrey T. Walsh | Director | May 29, 2026 |
| R Sanders Williams | Director | May 29, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Faraz Ali | Chief Executive Officer | Sep 11, 2026 |
| Tomohiro Higa | SVP, Finance | May 19, 2026 |
| Eric J Hyllengren | Chief Financial Officer | Jul 14, 2026 |
| Whittemore Tingley | Chief Medical Officer | Sep 11, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 17, 2026 | Faraz Ali | Sale | 5,020 | $0.71 |
| Aug 17, 2026 | Faraz Ali | Sale | 7,406 | $0.71 |
| Aug 17, 2026 | Faraz Ali | Sale | 5,837 | $0.71 |
| Aug 17, 2026 | Faraz Ali | Sale | 3,969 | $0.71 |
| Aug 17, 2026 | Faraz Ali | Sale | 5,020 | $0.71 |
| Aug 17, 2026 | Faraz Ali | Sale | 7,406 | $0.71 |
| Aug 17, 2026 | Faraz Ali | Sale | 5,837 | $0.71 |
| Aug 17, 2026 | Faraz Ali | Sale | 3,969 | $0.71 |
| Aug 17, 2026 | Faraz Ali | Sale | 5,020 | $0.71 |
| Aug 17, 2026 | Faraz Ali | Sale | 7,406 | $0.71 |
| Aug 17, 2026 | Faraz Ali | Sale | 5,837 | $0.71 |
| Aug 17, 2026 | Faraz Ali | Sale | 3,969 | $0.71 |
| Aug 17, 2026 | Faraz Ali | Sale | 5,020 | $0.71 |
| Aug 17, 2026 | Faraz Ali | Sale | 7,406 | $0.71 |
| Aug 17, 2026 | Faraz Ali | Sale | 5,837 | $0.71 |
TNYA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-90.60M | -0.59 | $-68.26M |
| Dec 31, 2024 | — | $-111.13M | -1.31 | $-90.50M |
| Dec 31, 2023 | — | $-124.08M | -1.68 | $-102.07M |
| Dec 31, 2022 | — | $-123.67M | -2.76 | $-104.42M |
| Dec 31, 2021 | — | $-72.72M | -4.10 | $-60.81M |
Latest balance sheet: total assets $93.54M, total liabilities $24.13M, cash $78.08M (as of Jun 30, 2026).
TNYA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $0.79 |
| May 6, 2026 | 8-K Item 2.02 (results) | $0.79 |
| Mar 11, 2026 | 8-K Item 2.02 (results) | $0.86 |
| Nov 10, 2025 | 8-K Item 2.02 (results) | $1.43 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $0.68 |
| May 7, 2025 | 8-K Item 2.02 (results) | $0.45 |
| Mar 10, 2025 | 8-K Item 2.02 (results) | $0.51 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $2.23 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 14, 2024 | 8-K Item 2.02 (results) | — |
| Mar 18, 2024 | 8-K Item 2.02 (results) | — |
| Nov 8, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on TNYA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.